Thyrocare Technologies Management
Management criteria checks 2/4
Thyrocare Technologies' CEO is Rahul Guha, appointed in May 2022, has a tenure of 2.58 years. total yearly compensation is ₹35.00M, comprised of 40% salary and 60% bonuses, including company stock and options. directly owns 0.1% of the company’s shares, worth ₹52.21M. The average tenure of the management team and the board of directors is 2 years and 2.9 years respectively.
Key information
Rahul Guha
Chief executive officer
₹35.0m
Total compensation
| CEO salary percentage | 40.0% |
| CEO tenure | 2.6yrs |
| CEO ownership | 0.1% |
| Management average tenure | 2yrs |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
Statutory Profit Doesn't Reflect How Good Thyrocare Technologies' (NSE:THYROCARE) Earnings Are
Oct 31
Thyrocare Technologies Limited (NSE:THYROCARE) Looks Just Right With A 26% Price Jump
Aug 01Thyrocare Technologies Limited (NSE:THYROCARE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Jul 26A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)
Jun 12Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult
Feb 29Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 04Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly
Dec 08Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 08Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively
Mar 23Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Mar 02Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First
Feb 01Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%
Jan 12
The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares
Dec 24Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive
Dec 17Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 30Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Nov 02Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates
Nov 01CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹840m |
| Jun 30 2024 | n/a | n/a | ₹776m |
| Mar 31 2024 | ₹35m | ₹14m | ₹708m |
| Dec 31 2023 | n/a | n/a | ₹655m |
| Sep 30 2023 | n/a | n/a | ₹648m |
| Jun 30 2023 | n/a | n/a | ₹599m |
| Mar 31 2023 | ₹32m | n/a | ₹645m |
Compensation vs Market: Rahul's total compensation ($USD411.22K) is about average for companies of similar size in the Indian market ($USD353.34K).
Compensation vs Earnings: Rahul's compensation has been consistent with company performance over the past year.
CEO
Rahul Guha (46 yo)
2.6yrs
Tenure
₹35,000,004
Compensation
Mr. Rahul Franklin Guha serves as President of Operations at API Holdings Limited since 2024. He is Managing Director, Chief Executive Officer and Director of Thyrocare Technologies Limited from May 04, 20...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Chairman | 2.6yrs | ₹35.00m | 0.10% ₹ 53.2m | |
| Chief Financial Officer | 1.3yrs | ₹5.55m | no data | |
| Chief Operating Officer | no data | ₹9.32m | 0.0030% ₹ 1.6m | |
| Company Secretary & Compliance Officer | 10.3yrs | ₹3.64m | 0.040% ₹ 21.0m | |
| Head of Strategy & Investor Relations | no data | no data | no data | |
| Chief Commercial Officer | less than a year | no data | no data | |
| Vice President | no data | ₹5.33m | 0.0020% ₹ 1.1m | |
| Strategy Manager | no data | no data | no data |
2.0yrs
Average Tenure
46yo
Average Age
Experienced Management: THYROCARE's management team is not considered experienced ( 2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Chairman | 2.6yrs | ₹35.00m | 0.10% ₹ 53.2m | |
| Non-Executive Independent Director | 7.3yrs | ₹240.00k | no data | |
| Non-Executive & Non-Independent Director | 3.3yrs | no data | no data | |
| Non Executive Director | 3.3yrs | no data | no data | |
| Non Executive Director | 3.2yrs | no data | no data | |
| Independent Director | 1.4yrs | ₹220.00k | no data | |
| Non-Executive Independent Director | 1.4yrs | ₹40.00k | no data | |
| Independent Director | no data | no data | no data | |
| Independent Director | less than a year | no data | no data |
2.9yrs
Average Tenure
36yo
Average Age
Experienced Board: THYROCARE's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 17:28 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Thyrocare Technologies Limited is covered by 13 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Alka Katiyar | Batlivala & Karani Securities India Pvt. Ltd. |
| Rahul Agarwal | CGS International |
| Kameswari V. S. Chavali | FirstCall Research |